Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Device Center Analyzes Why It Missed PMA Review Goals

This article was originally published in The Gray Sheet

Executive Summary

FDA pre-market approval reviews tend to take longer when the medical officer leaves the review team, when clinical trial data issues arise and when companies engage in "excessive" back and forth with FDA during the review process, according to a recent FDA analysis.

You may also be interested in...



HELP Committee Leaders Aim To Prevent Controversial Add-Ons To User Fee Bill

Members of the Senate HELP Committee expressed concerns that potential riders added to the FDA user fee bill could slow down passage and add more work for FDA staff.

Device Center Scientists Cite Business Interests As A Factor In Decision-Making

Union of Concerned Scientists survey finds that many FDA scientists feel that business interests affect agency decisions. Nevertheless, a strong majority said that the agency is effectively protecting public health.

Shuren: Budget Woes Will Have Big Impact On FDA Device Center

Pre-market review of device applications, among other core CDRH activities, would come to a virtual halt in the event of a federal government shutdown, according to Center Director Jeffrey Shuren.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT029929

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel